Результаты поиска

Clinical value and cost-effectiveness analysis of conditionally approved anticancer drugs in China from 2015 to 2023.

BackgroundThe conditional approval (CA) process in China was established in 2015 to expedite access to urgently-needed drugs, however, the clinical benefits of CA drugs and potential gaps between pre-approval and confirmatory trials remain uncertain. Herein, we aim to compare the clinical values between CA and non-CA anticancer drugs from 2015 to 2023, and to explore the relationship between clinical benefit and average daily cost of treatment of drugs.MethodsThis retrospective study analyzed anticancer drugs first approved in China [2015-2023] using data from National Medical Products Adminis

Clinical, economic and organizational impact of pharmacist interventions on injectable antineoplastic prescriptions: a prospective observational study.

BackgroundPharmacists play a key role in ensuring the safe use of injectable antineoplastics, which are considered as high-alert medications. Pharmaceutical analysis of injectable antineoplastic prescriptions aims to detect and prevent drug related problems by proposing pharmacist interventions (PI). The impact of this activity for patients, healthcare facilities and other health professionals is not completely known. This study aimed at describing the clinical, economic, and organizational impacts of PIs performed by pharmacists in a chemotherapy preparation unit.MethodsA prospective 10-week

Совпадение в полном тексте источника
… However, despite these security measures, there is always a residual risk of error, justifying the requirement for pharmaceutical analysis of injectable antineoplastic prescriptions. …

Relationship between chemotherapy-induced peripheral neuropathy and physical activity in cancer survivors: A prospective longitudinal study.

ObjectiveThe purpose of this research is to evaluate the relationship between the degree of peripheral neuropathy associated with treatment and physical activity through the use of objective indicators such as wristband activity tracker and subjective evaluations obtained through interviews.MethodsThis study included 11 patients with gynecological cancer, gastrointestinal cancer, and malignant lymphoma. Participants were requested to wear a wristband activity meter at two time points: early and mid-treatment. Activity-meter step counts were compared with factors such as energy expenditure and

Сопоставление результатов анализа ОК вирусов с составителем и биоаналогичным наследственным вирусом.

Редкое осложнение, связанное с лечением внутриутробного лейкоэнцефалопатии (ПМЛ); риск может быть стратифицирован с использованием антителного состояния вируса JC (JCV). При калькуляторах для оказания помощи в принятии клинических решений используются когортные данные, испытанные с использованием анализа Stratify-JCV. В ответ на обеспокоенность по поводу увеличения числа серопозитивных результатов JCV после перехода на биоаналоговый и соответствующий испытательный переключатель мы попытались понять клинические последствия. Включено в общей сложности 497 человек, имеющих MS, которые перешли из

Recent advances and challenges of cellular immunotherapies in lung cancer treatment.

Lung cancer is a major malignant tumor with high morbidity and fatality rates. For many years, traditional treatments for lung cancer have struggled to achieve a favorable outlook and prognosis. It is crucial to identify and innovate novel clinical therapeutic strategies and techniques to prevent tumor progression and prolong the survival time of patients with lung cancer. Cellular immunotherapies have revolutionized the treatment of malignant tumors and have been gradually applied in clinical practice. CAR-T therapy is the best-known cellular therapy and has achieved remarkable clinical outco

Protocol of the optimal study: Optimization of polypharmacy in geriatric oncology - A randomized controlled trial.

BackgroundPolypharmacy is very common in older cancer patients and these patients are particularly vulnerable to drug-drug interactions and adverse drug reactions because they often receive chemotherapy and symptom-relieving agents.MethodsThe primary aim of the randomized, controlled Optimization of Polypharmacy in Geriatric Oncology (OPTIMAL) trial is to test whether an advisory letter with the results of a comprehensive medication review conducted with the Fit fOR The Aged (FORTA) list to the caring physician in rehabilitation clinics improves the quality of life (QoL) of older cancer patien

Understanding the symptom experience and self-management strategies of adult hematopoietic stem cell transplantation patients during hospitalization: findings from a qualitative longitudinal study.

PurposeThe aim of this study was to explore the symptom experience and self-management strategies of adult hematopoietic stem cell transplantation patients during hospitalization.MethodsThis was a qualitative descriptive study. A heterogeneous sample of 19 patients who underwent hematopoietic stem cell transplantation from May to October 2021 were enrolled in the study. Semi-structured interviews were conducted at four time points during hospitalization, providing a total of 64 interview datasets.ResultsFour themes and 11 subthemes reflecting the symptom experience and self-management strategi

Developing a patient portal for haematology patients requires involvement of all stakeholders and a customised design, tailored to the individual needs.

BackgroundElectronic patient portals are increasingly being implemented, also in (haemato) oncology. However, portal usage is low and depends on user and provider engagement. We explored wishes, expectations and thoughts of patients with a haematologic malignancy and their physicians with regard to the electronic patient portal.MethodsBased on insights from literature and a focus group discussion we built a 44-item questionnaire. This questionnaire was spread amongst patients with a haematologic malignancy at the outpatient clinic that was not yet exposed to patient portal facilities. Haematol

Руководящие принципы иммунизации лиц с хроническими неврологическими расстройствами: систематический обзор.

КОЛИЧЕСТВО: Люди с хроническими неврологическими расстройствами могут быть подвержены серьезным последствиям инфекций, предотвращаемых с помощью вакцин. Вместе с тем рекомендации в отношении иммунизации этих пациентов могут быть сопряжены с трудностями при их выявлении и применении. Цель этого систематического обзора заключалась в определении и описании официальных руководящих принципов профилактической активной иммунизации лиц с хроническими неврологическими расстройствами. МЕТОДЫ: Этот систематический обзор был проведен в соответствии с предпочтенными элементами отчетности для системных обзо

Anterior Corpectomy Versus Posterior Pedicle Screw Fixation With 5.5-mm Rods for Metastatic Spinal Tumor Located in the Cervicothoracic Junction.

OBJECTIVE: This study compared the efficacy of posterior pedicle screw fixation with 5.5-mm rods (PPSF5.5) with anterior corpectomy (AC) for metastatic cervicothoracic junction (CTJ) tumors. METHODS: This retrospective analysis included patients with CTJ tumors who underwent PPSF5.5 or AC from January 2000 to December 2023. Data collected included demographics, surgical details, clinical outcomes (visual analogue scale scores for neck or back pain, Spinal Instability Neoplastic Scale score, McCormick scale, Nurick grade, and Eastern Cooperative Oncology Group score), radiologic results (cervi

Долгосрочное управление и последовательность терапии для пациентов с повторным множественным склерозом во Франции: исследование вигнета.

ВВЕДЕНИЕ: Мы проанализировали предписания, касающиеся принятия решений о повторном использовании вигнетта в гипотетическом случае склероза (RMS) 111 неврологов (участвующих врачей) во Франции. МЕТОДЫ: Участвующим врачам было представлено шесть вигнеттов, каждый из которых основан на реалистическом, гипотетическим клиническом взаимодействии между неврологом и людьми с активной или высокоактивной РМО, с предварительным лечением с помощью терапии, направленной на изменение болезней, или без такового.Результаты: 111 участвующих врачей рассмотрели эти случаи и рекомендовали лечение. Наши данные сви

Research on predicting the progression of multiple myeloma treated with bortezomib based on multimodal ensemble learning.

BackgroundMultiple myeloma (MM) is a malignancy characterized by abnormal plasma cell proliferation. While bortezomib has improved outcomes, significant individual variability persists. Accurate early prediction of patient progression is crucial for optimizing therapeutic intensity and improving long-term survival. Developing an automated, multimodal prediction model can provide clinicians with a robust tool for personalized prognosis, thereby reducing the burden of ineffective treatments on patients.MethodsWe enrolled 207 newly diagnosed MM (NDMM) patients treated with bortezomib. Based on 2-

A case report of metastatic hepatocellular carcinoma in the mandible and coracoid process: A rare presentation.

RationaleWe report a rare case of hepatocellular carcinoma (HCC) with metastases to the mandible and coracoid process of scapula without evidence of lung involvement.Patients concernsThe patient was diagnosed with HCC, presented 5 months later with right lower tooth pain, swelling over the right mandible area and right shoulder pain.DiagnosesHistopathological examination of mandible showed findings suggestive of metastatic HCC. Magnetic resonance imaging (MRI) of the right shoulder revealed findings of irregular enhancing lesion at the right coracoid process causing erosion of the coracoid pro

Design specifications for biomedical virtual twins in engineered adoptive cellular immunotherapies.

In (immune)oncology, virtual twins (VTs) offer patient-individual decision support. Nevertheless, current VTs do not incorporate the unique properties of engineered adoptive cellular immunotherapies (eACIs). Here, we outline the minimal design specifications for VTs for engineered ACIs (eACI-VTs) to model the complex interplay between cell product and patient physiology. We motivate utilizing VTs in eACIs to provide decision support and reflect on how eACI-VTs can support the widespread use of eACIs.

Совпадение в полном тексте источника
… Sensitive data, like genetic data, receives increased protection by the GDPR, requiring minimization and security measures, e.g., pseudonymization. …

Cancer survivors not participating in observational patient-reported outcome studies have a lower survival compared to participants: the population-based PROFILES registry.

PurposeThe 'Patient Reported Outcomes Following Initial treatment and Long-term Evaluation of Survivorship' (PROFILES) registry collects patient-reported outcomes (PROs) from short- and long-term cancer survivors in the Netherlands, in a population-based setting. The aim of this analysis is to assess the generalizability of observational PRO research among cancer survivors by comparing socio-demographic and clinical characteristics, and survival of participants and non-participants in cancer survivors invited for questionnaire research through the PROFILES registry.MethodsBetween 2008 and 2015

Second-Class Care: How Immigration Law Transforms Clinical Practice in the Safety Net.

This article examines how U.S. immigration law extends into the health care safety net, enacting medical legal violence that diminishes noncitizens' health chances and transforms clinical practices. Drawing on interviews with health care workers in three U.S. states from 2015 to 2020, I ask how federal citizenship-based exclusions within an already stratified health care system shape the clinical trajectories of noncitizens in safety-net institutions. Focusing specifically on cancer care, I find that increasingly anti-immigrant federal policies often reshape clinical practices toward noncitize

Eliminating REMS for CAR T-Cell Therapies: An Opportunity to Improve Access.

Autologous Chimeric antigen receptor (CAR) T-cell therapies have demonstrated substantial efficacy in patients with relapsed or refractory hematologic malignancies; however, their implementation has been constrained by regulatory barriers. Risk Evaluation and Mitigation Strategies (REMS), mandated by the U.S. Food and Drug Administration (FDA), were initially implemented to mitigate risks associated with cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), and other treatment-related toxicities. On 27 June 2025, the FDA removed REMS requirements for

Obesity as a Multifactorial Chronic Disease: Molecular Mechanisms, Systemic Impact, and Emerging Digital Interventions.

Obesity is a multifactorial chronic disease resulting from complex genetic, molecular, environmental, and behavioral interactions. Its prevalence rises worldwide, affecting cardiovascular, metabolic, oncological, hepatic, respiratory, and skeletal health. Beyond caloric excess, genetic predisposition, epigenetic modifications, gut microbiota dysbiosis, endocrine-disrupting agents, circadian misalignment, and intergenerational and prenatal influences are critical determinants of obesity risk. Core pathophysiological mechanisms include insulin resistance, dyslipidemia, chronic low-grade inflamma

Development of a Patient-Centered Preference Tool for Patients With Hematologic Malignancies: Protocol for a Mixed Methods Study.

BackgroundThe approval of novel therapies for patients diagnosed with hematologic malignancies have improved survival outcomes but increased the challenge of aligning chemotherapy choices with patient preferences. We previously developed paper versions of a discrete choice experiment (DCE) and a best-worst scaling (BWS) instrument to quantify the treatment outcome preferences of patients with hematologic malignancies to inform shared decision making.ObjectiveWe aim to develop an electronic health care tool (EHT) to guide clinical decision making that uses either a BWS or DCE instrument to capt

Повышенное использование медицинских услуг two За несколько десятилетий до первого демиелионирующего события, которое отличается по возрасту и полу.

ЦЕЛЬ: Повышение уровня использования медицинских услуг до появления множественных склерозов (MS) говорит о том, что более ранняя возможность для выявления MS существует. Однако их сроки и социально-демографические последствия неясны. Мы изучили показатели использования медицинских услуг (а также в разбивке по возрасту/полу) для >two десятилетия до начала работы. МЕТОДЫ: Мы идентифицировали людей с MS (PwMS), используя административные данные Канады (Ontario) и Швеции (MS).1991-2020) ("административная" группа) и шведский регистр MS ("клиническая" группа). В первом (административном) или симпто